NCT02225197View on ClinicalTrials.gov

A Phase II Trial of CyberKnife Radiosurgery to Perioptic Tumors

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Tumor, Benign, Optic Nerve
Interventions
RADIATION

CyberKnife Radiosurgery

25 Gy delivered in 5 fractions of 5 Gy per fraction

Trial Locations (1)

61761

Community Cancer Center, Normal

All Listed Sponsors
lead

Community Cancer Center, Normal, Illinois

OTHER

NCT02225197 - A Phase II Trial of CyberKnife Radiosurgery to Perioptic Tumors | Biotech Hunter | Biotech Hunter